Integrated LC–MS Profiling, In Vitro Antioxidant Activity, and Exploratory Molecular Docking of Selected Mangifera odorata Fruit Extract Constituents with KEAP1
Abstract
Natural products remain important sources of antioxidant compounds, particularly among underexplored tropical fruits. This study evaluated the antioxidant potential of Kweni (Mangifera odorata) fruit extract by integrating LC–MS profiling, in vitro assays, and molecular docking. Putative compounds were annotated by spectral-library matching. Hydroxyl radical (•OH) and hydrogen peroxide (H₂O₂) scavenging and metal-ion chelating activities were measured, and the corresponding half-maximal inhibitory concentrations (IC₅₀) were determined. Five flavonoid-related candidates (eriodictyol, astilbin, apigetrin, naringenin, and genistein) were selected for docking against Kelch-like ECH-associated protein 1 (KEAP1). The extract showed measurable activity in all three assays, with IC₅₀ values of 67.240 µg/mL for metal-ion chelation, 83.03 µg/mL for H₂O₂ scavenging, and 84.17 µg/mL for •OH scavenging. Among the selected candidates, astilbin and the tentatively annotated apigetrin produced the most favorable Vina scores (−10.2 kcal/mol) and predicted contacts within the modeled KEAP1 pocket. Because the compounds were putatively annotated and the assays used the whole extract, the observed activities cannot be assigned to individual constituents. The docking results indicate possible ligand–KEAP1 interactions but do not demonstrate KEAP1 inhibition, disruption of KEAP1–NRF2 binding, or NRF2 activation. Authentic standards, isolated compounds, biochemical binding assays, and cellular studies are required for confirmation.
Full text article
Generated from XML file
References
To be published
Authors
1.
Mashuri M, Noor Z, Suhartono E, Husna Dharma Putera, Kania N, Effendy RR, Iskandar I. Integrated LC–MS Profiling, In Vitro Antioxidant Activity, and Exploratory Molecular Docking of Selected Mangifera odorata Fruit Extract Constituents with KEAP1. Borneo J Pharm [Internet]. 2026Sep.30 [cited 2026Oct.3];9(3). Available from: https://journal.umpr.ac.id/index.php/bjop/article/view/12172
Copyright (c) 2026 Mashuri Mashuri, Zairin Noor, Eko Suhartono, Husna Dharma Putera, Nia Kania, Ristaniah Rose Effendy, Iskandar Iskandar

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors continue to retain the copyright to the article if the article is published in the Borneo Journal of Pharmacy. They will also retain the publishing rights to the article without any restrictions.
Authors who publish in this journal agree to the following terms:
- Any article on the copyright is retained by the author(s).
- The author grants the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share work with an acknowledgment of the work authors and initial publications in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of published articles (e.g., post-institutional repository) or publish them in a book, with acknowledgment of their initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) prior to and during the submission process. This can lead to productive exchanges and earlier and greater citations of published work.
- The article and any associated published material are distributed under the Creative Commons Attribution-ShareAlike 4.0 International License.